Sri Lankan health authorities have warned the public not to be misled by sensational claims about Russia’s so-called cancer vaccine ‘Enteromix’, emphasizing that it is still at a pre-clinical stage and has not yet demonstrated proven effectiveness through scientific validation.
The caution follows a wave of viral posts and international media reports describing Enteromix as a “100 per cent effective” cancer cure, assertions that experts have dismissed as scientifically unverified and premature.
“While any advancement in cancer treatment is welcome, this vaccine is still in the early stages of development,” a Health Ministry official told the media .
The official added that clinical trials and peer-reviewed research are essential before drawing any conclusions about its safety or efficacy.
Developed by Russia’s National Medical Research Radiological Centre, Enteromix reportedly uses mRNA technology similar to that used in COVID-19 vaccines, with the goal of training the immune system to attack cancer cells. Early reports suggest promising tumour responses in colorectal cancer studies, but experts emphasize that pre-clinical results — observed only in laboratory or animal models — cannot be taken as proof of human effectiveness.
